+44 (0) 20 3997 7634 | sales@fbkmed.com
Home > Assessment of Response to Tyrosine Kinase Inhibitors in Metastatic Renal Cell Cancer: CT Texture as a Predictive Biomarker
03/07/11
Share on social media:
25/03/24
Bleepa Feedback Medical Feedback PLC
21/03/24
21/02/24